Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Beasley

Showing results (71-80 of 412) with videos related to

Pageof 42
Sort By:
The European Respiratory Journal|April 16, 2004
Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysisM Masoli, S Holt, M Weatherall, et al.
Archives of Disease in Childhood|September 24, 2004
Systematic review of the dose-response relation of inhaled fluticasone propionateM Masoli, M Weatherall, S Holt, et al.
Lancet (London, England)|April 20, 1991
Beta 2-agonists and New Zealand asthma mortalityC Burgess, J Crane, N Pearce, et al.
Thorax|February 1, 1994
Extrapulmonary effects of fenoterol and salbutamol in normal subjectsJ Crane, C Burgess, R Beasley, et al.
The New Zealand Medical Journal|March 27, 1991
Bronchial responsiveness during regular fenoterol therapyR Beasley, J Crane, C Burgess, et al.
The New Zealand Medical Journal|April 10, 1991
Asthma severity and fenoterol prescribingJ Crane, N Pearce, R Beasley, et al.
Clinical Science (London, England : 1979)|December 1, 1987
The pathogenesis and significance of bronchial hyper-responsiveness in airways diseaseS T Holgate, R Beasley, O P Twentyman
Chest|October 23, 1997
Fenoterol, asthma deaths, and asthma severityN Pearce, C Burgess, J Crane, et al.
The Journal of Allergy and Clinical Immunology|August 19, 1999
Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality?R Beasley, N Pearce, J Crane, et al.
The Journal of Allergy and Clinical Immunology|September 14, 1999
The magnitude of the effect of smaller family sizes on the increase in the prevalence of asthma and hay fever in the United Kingdom and New ZealandK Wickens, J Crane, N Pearce, et al.
Pageof 42

Showing results (71-80 of 412) with videos related to

Sort By:
Pageof 42
The European Respiratory Journal|April 16, 2004
Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysisM Masoli, S Holt, M Weatherall, et al.
Archives of Disease in Childhood|September 24, 2004
Systematic review of the dose-response relation of inhaled fluticasone propionateM Masoli, M Weatherall, S Holt, et al.
Lancet (London, England)|April 20, 1991
Beta 2-agonists and New Zealand asthma mortalityC Burgess, J Crane, N Pearce, et al.
Thorax|February 1, 1994
Extrapulmonary effects of fenoterol and salbutamol in normal subjectsJ Crane, C Burgess, R Beasley, et al.
The New Zealand Medical Journal|March 27, 1991
Bronchial responsiveness during regular fenoterol therapyR Beasley, J Crane, C Burgess, et al.
The New Zealand Medical Journal|April 10, 1991
Asthma severity and fenoterol prescribingJ Crane, N Pearce, R Beasley, et al.
Clinical Science (London, England : 1979)|December 1, 1987
The pathogenesis and significance of bronchial hyper-responsiveness in airways diseaseS T Holgate, R Beasley, O P Twentyman
Chest|October 23, 1997
Fenoterol, asthma deaths, and asthma severityN Pearce, C Burgess, J Crane, et al.
The Journal of Allergy and Clinical Immunology|August 19, 1999
Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality?R Beasley, N Pearce, J Crane, et al.
The Journal of Allergy and Clinical Immunology|September 14, 1999
The magnitude of the effect of smaller family sizes on the increase in the prevalence of asthma and hay fever in the United Kingdom and New ZealandK Wickens, J Crane, N Pearce, et al.
Pageof 42